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Abstract
We use a computational modelling approach to explore whether it is possible to infer a
solid tumour’s cellular proliferative hierarchy under the assumptions of the cancer stem
cell hypothesis and neutral evolution. We focus on inferring the symmetric division
probability for cancer stem cells, since this is believed to be a key driver of progression and
therapeutic response. Motivated by the advent of multi-region sampling and resulting
opportunities to infer tumour evolutionary history, we focus on a suite of statistical
measures of the phylogenetic trees resulting from the tumour’s evolution in different
regions of parameter space and through time. We find strikingly different patterns in these
measures for changing symmetric division probability which hinge on the inclusion of
spatial constraints. These results give us a starting point to begin stratifying tumours by
this biological parameter and also generate a number of actionable clinical and biological
hypotheses including changes during therapy, and through tumour evolution.
http://mc.manuscriptcentral.com/systbiol
© The Author(s) 2019. Published by Oxford University Press, on behalf of the Society of Systematic Biologists. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the 
original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com 
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/s
y
s
b
io
/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/s
y
s
b
io
/s
y
z
0
7
0
/5
6
0
9
1
2
9
 b
y
 U
n
iv
e
rs
ity
 o
f S
h
e
ffie
ld
 u
s
e
r o
n
 1
3
 N
o
v
e
m
b
e
r 2
0
1
9
2 SCOTT ET AL.
Key words : Cancer, Evolution, Phylogenetics.
The cancer stem cell hypothesis (CSCH) posits that tumours are composed of a
hierarchy of cells with varying proliferative capacities. Under this hypothesis, a
subpopulation of ‘cancer stem cells’, also termed tumour initiating cells (TICs), are able to
self-renew through symmetric division and also to differentiate into tumour cells
resembling transit amplifying cells (TACs) through asymmetric division (Fig 1A), giving
rise to the entire diversity of cells within a tumour (Fialkow et al. 1967). The CSCH
provides a conceptual framework by which to understand many different aspects of cancer
progression, including: the occurrence of functional heterogeneity despite genetically
identical states (Magee et al. 2012, Sottoriva et al. 2010, Vlashi et al. 2011); resistance to
chemotherapy (Chen et al. 2012, Werner et al. 2016) and radiotherapy (Bao et al. 2006,
Dhawan et al. 2014, Diehn et al. 2009); recurrence (Dingli & Michor 2006); and
metastasis (Pang et al. 2010). Despite its popularity, the CSCH has been the subject of
continual debate and modification in order to maintain compatibility with experimental
observations (Gilbertson & Graham 2012, O’Connor et al. 2014, Scott et al. 2019).
While the specifics of the CSCH are still a matter of debate, the clinical relevance of
those cells with traits ascribed to TICs is clear. However, our ability to measure their
dynamics in a clinical setting remains lacking. In vivo measurement efforts are limited to
carefully conducted live imaging in genetically engineered mice (Ritsma et al. 2014), or
genetic labelling and subsequent lineage tracing (Driessens et al. 2012). Although in vitro
systems are better suited to the extraction of these parameters, to date little has been
done to quantify them, as technically demanding single-cell lineage tracing (Lathia et al.
2011) is required. These experimental difficulties speak to the need for more theoretical
work in this area, especially to propose metrics for quantifying proliferative parameters
such as TIC symmetric division probability (Fig 1A) from clinical data. This is of
particular importance as there is mounting evidence for the effect of proliferative hierarchy
http://mc.manuscriptcentral.com/systbiol
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 3
on response to radiotherapy (Tamura et al. 2010) and chemotherapy (Chen et al. 2012),
and microenvironmental factors such as hypoxia (Conley et al. 2012, Dhawan, Tonekaboni,
Taube, Hu, Sphyris, Mani & Kohandel 2016), acidosis (Hjelmeland et al. 2011) growth
factors (Doetsch et al. 2002), and even stromal cell co-operation or co-option (Liu et al.
2011, Vermeulen et al. 2010) have been shown to perturb this system. In summary, TIC
symmetric division rate and somatic mutation rate are both specific parameters of interest
in cancer biology, and these form the focus of the present modelling.
Several published mathematical models, using different formalisms and considering
different aspects of heterogeneity, have predicted that the evolution of a solid tumour
should depend strongly on whether or not it exhibits a proliferative hierarchy, and on the
parameters of such a hierarchy. These models have included spatial proliferation
constraints, microenvironmental heterogeneity and selective pressures, and the noted
differences include shape, clonal heterogeneity, rate of evolution and growth dynamics.
Werner et al. (2011) specifically studied the differences in bulk tumour behaviour between
tumours arising from mutant TICs and TACs in a non-spatial context. In a spatial
context, the work of Sottoriva et al. (2010), Sottoriva & Tavare´ (2011), Enderling et al.
(2009) and Morton et al. (2011) represent the first papers where it was shown that the
parameters governing TAC dynamics can constrain tumour growth, and also to show that
TIC-driven tumours have significantly different spatial growth patterns: specifically, that
they exhibit ‘patchy’ growth. In none of these models, except Sprouffske et al. (2013), in
which the main question centred on TAC numbers, were these differences studied across
TIC symmetric division probabilities, which is a key parameter governing the hierarchy,
and one that is exceedingly difficult to measure or perturb in vitro or in vivo.
To describe the evolutionary relationship between cells in a multicellular tissue, we
require a phylogenetic approach. While the use of objective, genetic information to infer
phylogenetic trees has a long history in evolutionary biology, its application to cancer
evolution is much more recent, giving rise in the last decade to a subfield recently dubbed
http://mc.manuscriptcentral.com/systbiol
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4 SCOTT ET AL.
‘PhyloOncology’ by Somarelli et al. (2016). Using phylogenies reconstructed from spatially
separated biopsies and informatic algorithms, many aspects of tumour evolution have
begun to be elucidated (Gerlinger et al. 2014), including the genetic heterogeneity present
within a primary tumour (Sottoriva et al. 2013), the origin of individual metastatic
tumours within the primary site (Gerlinger et al. 2012, Naxerova & Jain 2015), the earliest
events driving progression and metastasis (Zhao et al. 2016), and the effect of
chemotherapy on primary and metastatic sites (Faltas et al. 2016, Murugaesu et al. 2015).
In addition to these sorts of questions, there are precedents in other fields for using
phylogenetic information, integrated with population dynamics to infer other underlying
biological processes – a technique termed phylodynamics (Grenfell et al. 2004). For
example, Leventhal et al. (2012) proposed that the phylogenetic tree contains a
“fingerprint” that can be used to determine the evolutionary process driving the
population in question. Modelling the spread of HIV within a contact network, the authors
investigated whether the network structure could be inferred from the resulting disease
phylogenies. To address this question, the authors simulated a range of epidemics on
several families of random graphs and measured the resulting phylogenetic trees, finding
that certain tree-based measures could discriminate between the qualitatively different
families of random graph structures considered.
We may expect cancer cell phylogenies to look quite different to viral phylogenies.
Nevertheless, these precedents motivate us to ask whether a similar approach could be
used to discriminate between in silico tumours with different symmetric division rates. To
test this hypothesis, here we study the effect of TIC symmetric division probability on
tumour evolution using a computational modelling approach. We focus on observed
patterns in reconstructed phylogenetic trees across a range of symmetric division
probabilities. The estimation of this proliferative parameter from clinical data could help
improve our understanding of the effect of therapies on tumour growth dynamics, and our
ability to stratify tumours for consideration of different therapies. In this way, we seek to
http://mc.manuscriptcentral.com/systbiol
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 5
provide translatable measures to aid in understanding tumour biology: to use
mathematical modelling to ‘see the invisible’.
The remainder of this paper is structured as follows. We first present a spatial
stochastic model of tumour growth under a proliferative hierarchy with neutral mutations,
which we embed on a two-dimensional lattice to enable the study of the effect of spatial
constraints. Next, we develop an algorithm to reconstruct the branched phylogenetic
structure from each realization of our tumour growth model. We apply a range of
statistical measures of phylogenetic tree shape to simulation outputs for comparison. We
explore the temporal dynamics of these measures over the course of tumour growth to
assess whether they are robust to tumour size changes, and then to changes in mutation
frequency. Finally, we discuss the possible clinical utility of these measures.
Materials and Methods
Model development
Here, we describe the development of a two-dimensional, lattice-embedded cellular
automaton (CA) model of tumour growth with contact inhibition growing under neutral
evolution and a proliferative hierarchy. We also develop a non-spatial companion model in
order to assess the role of spatial constraints on the evolutionary process.
Proliferative hierarchy For both models, we consider a proliferative hierarchy
comprising two cell types, TICs and TACs. We assume that each TIC divides
symmetrically with probability α, creating two TICs, and asymmetrically with probability
1− α, creating one TIC and one TAC. For simplicity, we assume that α takes a constant
value for all cells in a given simulation, and is not dependent on the mutation rate (see
below). Note that in practice, microenvironmental parameters such as nutrient
deprivation (Flavahan et al. 2013), acidity (Hjelmeland et al. 2011) and
hypoxia (Heddleston et al. 2009, Li et al. 2009), as well as accumulated mutations such as
http://mc.manuscriptcentral.com/systbiol
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6 SCOTT ET AL.
those commonly observed in colorectal cancers (Baker et al. 2014), are all known to be
capable of affecting symmetric division probability among cells in a tumour. As it has been
shown theoretically that the overall population dynamics of TIC-driven tumours is
equivalent with or without TIC symmetric differentiation (Rodriguez-Brenes et al. 2011)
(when a TIC divides to create two TACs), and as the lineage extinction possible in this
case would significantly complicate our phylogenetic analysis, we make the simplifying
assumption that there is no symmetric differentiation. We do not rule out that the
addition of symmetric differentiation could affect phylodynamics, but leave that question
for further study.
We assume that every TAC division is symmetric, creating two TACs, but only
allow this to progress for β rounds of division, after which the TAC will die if chosen to
divide again. Here β represents the replicative potential of TACs, and is posited to
represent telomere length (Poleszczuk et al. 2014). Previous theoretical work has shown
that tumour growth kinetics in spatially constrained geometries are strongly affected by
the value of β (Morton et al. 2011). In particular, if β > 5, then simulated tumours
experience unrealistically lengthy growth delays. Therefore we follow a previously used
assumption (Sottoriva et al. 2010, Sprouffske et al. 2013) and fix β = 4. This mode of
growth and differentiation is illustrated in Fig 1A. For simplicity, we neglect cell death,
which could disrupt growth patterns. Indeed, Williams et al. (2016) have shown that the
overall patterns of mutations, as measured by variant allele frequencies, is changed. The
addition of cell death in this model is therefore a natural avenue for future work.
Neutral evolution To understand the effects of neutral evolution on tumours with
differing proliferative hierarchies, we extend our model of tumour growth under a
proliferative hierarchy to include random mutations. At each cell division, there is a
possibility that one or more mutations occur. To determine the number of mutations
accumulated by a given daughter cell, we independently draw a random number from a
Poisson distribution with expectation λ. We assume for simplicity that every mutation
http://mc.manuscriptcentral.com/systbiol
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 7
Fig. 1.
arising in our model is unique. This ‘infinite sites’ assumption is usually ascribed
to Kimura (1969).
For simplicity, we assume that mutations confer no advantage, disadvantage or any
other phenotypic change and therefore serve only as a method by which to track clonal
lineages (i.e. they are neutral (Williams et al. 2016)). This assumption could in principle
be loosened to allow for positive selection (Bignell et al. 2010), or a balance of positive and
negative selection (McFarland et al. 2013). A schematic of this model of evolution, and
labelling scheme, is shown in Fig 1B.
For computational efficiency, instead of storing a genome of length n (G ∈ {0, 1}n),
we record a unique integer flag only for the most recent mutation accumulated within a
cell, which is passed down to its progeny, unless a mutation occurs, in which case a new
flag (the next integer) is assigned. We also record each mutation event in the form of an
ordered pair (parent flag, child flag), so that the complete genome, G, can be
http://mc.manuscriptcentral.com/systbiol
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8 SCOTT ET AL.
reconstructed for future use, and the length will be only as long as is needed to represent
the changes which occurred during the simulation. As they are the only cells capable of
forming tumours on their own, and infinite replication, we follow previous works in
considering new mutations to accrue only in TICs (Sottoriva et al. 2010, Sottoriva &
Tavare´ 2011, Sprouffske et al. 2013, Poleszczuk et al. 2015). A natural extension for human
cancer would be to consider instead sequences formed of DNA characters ATCG.
Non-spatial model implementation
To implement a first version of our hierarchical model with neutral evolution, we
consider the case in which there are no spatial constraints – which could be a sensible
model for liquid tumours like leukemias which are well mixed in the blood. We initialize
our simulation with a single TIC. We then implement discrete updates, which we will term
‘time steps’. As we are not studying temporal dynamics here, we do not prescribe any
proper dimension to this time. At each discrete time step we choose a cell uniformly at
random from the population to either divide and possibly mutate, or die. Our simulation is
considered complete when the total population of cells reaches a prescribed number.
If the cell is a TIC, then we first draw a random number, r, from U[0, 1] and
compare it to the probability of symmetric division, α. If r < α, then the cell divides
symmetrically, and we draw the number of new mutations accumulated in each daughter
independently from Poisson(λ). A new TIC daughter is then generated and given a
mutational ‘identity’ which is the mathematical sum of the parent cell’s identity and the
number of new mutations. The parental cell is also updated by changing its identity based
on the number of new mutations it accrues, if any. If the cell is not determined to divide
symmetrically, then it divides asymmetrically and a TAC daughter is created with age 0
and the parental TIC is updated for new mutations as above, see Fig 1.
If the chosen cell is instead a TAC, then we first check that its age is less than the
allowed TAC age, β. If the age is equal to the allowed TAC age, then the cell dies. If the age
http://mc.manuscriptcentral.com/systbiol
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/s
y
s
b
io
/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/s
y
s
b
io
/s
y
z
0
7
0
/5
6
0
9
1
2
9
 b
y
 U
n
iv
e
rs
ity
 o
f S
h
e
ffie
ld
 u
s
e
r o
n
 1
3
 N
o
v
e
m
b
e
r 2
0
1
9
INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 9
is less than the allowed TAC age, then the cell ages and divides, and a new daughter with
the same identification is created, whereupon the loop continues (see Fig 1 for schematic).
Spatial model implementation
As we are interested in the effect of the proliferative hierarchy on the neutral
evolutionary process in solid, spatially constrained tumours, we embed our cell-based
model in a two-dimensional square lattice. While recent work has shown some qualitative
differences in vascularised CA models between two and three dimensions, using a
two-dimensional lattice for unvascularised tissue is a common simplification (Anderson &
Chaplain 1998, Alarco´n et al. 2006, Gerlee & Anderson 2008, Scott et al. 2016) that allows
spatial constraints to be studied in a computationally tractable manner. In addition to the
above description of cell proliferation, we consider cell proliferation to be modulated by
contact inhibition (Anderson 2005). A cell is allowed to divide only if at least one of the
eight adjacent lattice sites (north, south, east, west, and diagonal neighbours) is
unoccupied; if this is not the case, then we consider the cell to be in a quiescent state that
may be exited when space becomes available. At each time step, each ‘cell’ has an
opportunity to divide given that it has space to do so. Cells are chosen uniformly at
random for updates from the entire population to avoid order bias. Apart from these
spatial effects, the model is otherwise identical to the non-spatial model presented earlier.
Cell-type specific rules If space is available, and the cell is a TIC, then the type of
division is determined by choosing a uniform random number, r, from [0, 1]. If r < α, then
the TIC divides symmetrically, creating another TIC that is placed uniformly at random in
one of the free neighbouring lattice sites. The parent and daughter TICs will independently
acquire a random number of new mutations, as described above. If r > α, then the TIC
divides asymmetrically, creating a TAC that is placed uniformly at random in one of the
free neighbouring lattice sites. The daughter TAC is created with the same mutation
http://mc.manuscriptcentral.com/systbiol
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10 SCOTT ET AL.
identity (ID) as the parent, and age = 0, while the parent TIC will independently acquire
a random number of new mutations, as described above.
If the chosen cell is instead a TAC, then the check after available space is a check of
the cell’s proliferative age, which is the number of divisions as a TAC. If the TAC age is
equal to the replicative potential, β, then the TAC dies, at which point it is removed from
the simulation. If the TAC age is less than β, then we create a new TAC daughter and
place it uniformly at random in one of the free neighbouring lattice sites. The parent and
daughter TACs share the same mutation ID and their age is updated to be one more than
the age of the originally chosen TAC.
Full implementation
The full CA flow-chart, represented in Fig 1C, schematises the entire process of cell
fate decisions that each cell undergoes at each time step in the spatial model. In the top
panel, the rule set followed by the TICs is represented to include differentiation and
Fig. 2.
http://mc.manuscriptcentral.com/systbiol
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 11
mutation. In the bottom panel, the TAC rule set is defined to include death by terminal
differentiation and TAC aging. An example simulation of tumour growth over time is
shown in Fig 2, where the effect of lowering α can be seen on overall tumour growth
kinetics, where the colour-bar represents the current clonal state (mutation ID) of a given
clone.
Recovering phylogenetic trees from simulation
While experimentalists and clinicians can only infer phylogenies from incomplete
data, reconstruction of the ‘true’ phylogeny is possible in our model as we can record the
entire life history of the simulated tumour. Thus, we can test whether phylogenetic
tree-based measures are able to discriminate TIC symmetric division probability in the
case where the ‘ground truth’ is known. At each time step we record the spatial location of
each individual cell with its mutation ID, which is our CA state vector. Additionally, we
record the evolutionary ‘life history’ as a list of ordered pairs of every mutation event
(parent mutational ID, child mutational ID). We then recursively construct the
phylogenetic tree from this life history.
Phylogenetic tree reconstruction algorithm To create the complete tree data
structure required for our quantitative analyses we use the information encoding the
mutation events from our stochastic simulation. To this end, we create a list of unique
parent-child pairs using the life history of mutation events. We then apply an iterative
process in which each child is added as a subnode below the parent (from the unique
parent-child pair). This process is continued until all parent-child pairs are added to the
structure, and the tree is complete. The simulation code and functions to create these trees
and calculate the metrics is freely available on request.
Qualitative comparison of reconstructed trees To compare phylogenies from
simulations with different underlying parameter values, we first construct and visualize the
http://mc.manuscriptcentral.com/systbiol
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12 SCOTT ET AL.
phylogenies constructed from three example simulations with differing TIC symmetric
division probabilities in Fig 3. It is clear by inspection that the number of mutations
increases with symmetric division probability (more branches). However, the tree structure
is not as easy to parse visually. For ease of visualization the trees depicted in Fig 3 have
been pruned of all terminal nodes (also called leaves) with no children of their own. While
this transformation does affect the quantitative results, it does not qualitatively affect the
resultant phylogenetic tree statistic ranks (see Fig 8). All analyses shown will utilize the
full trees.
Candidate tree-based measures for model comparison
Visual inspection of Fig 3 suggests that simulations with different TIC symmetric
division probabilities generate distinct phylogenetic trees. However, to draw meaningful
conclusions we must perform a quantitative comparison. Here we present several measures
useful in summarising and comparing phylogenetic trees. The most commonly studied
property of a phylogenetic tree’s shape is its balance, defined as the degree to which
internal nodes (branch points) have the same number of children as one another. Balance
(or imbalance) indices depend only on the branching topology of trees, and not on other
factors like branch length or other features of the terminal branches (leaves). Since the first
balance index by Sackin (1972), many others have been proposed with slightly differing
properties (Mir et al. 2013). One of the first papers to present a systematic comparison of
a suite of balance indices (often denoted with the letter ‘B’) and indices of imbalance
(denoted with ‘I’) was by Shao & Sokal (1990), who reported striking differences between
the studies’ measures. Their central message was that different measures on trees can give
insight into different aspects of the underlying processes governing the interactions, and
one should thus consider several measures for any given tree or family of trees. In this
study we will consider several tree topology-based measures.
Before describing the measures, it is worthwhile to briefly define the terms which
http://mc.manuscriptcentral.com/systbiol
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/s
y
s
b
io
/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/s
y
s
b
io
/s
y
z
0
7
0
/5
6
0
9
1
2
9
 b
y
 U
n
iv
e
rs
ity
 o
f S
h
e
ffie
ld
 u
s
e
r o
n
 1
3
 N
o
v
e
m
b
e
r 2
0
1
9
INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 13
Fig. 3.
are used to describe trees, and the two basic underlying stochastic models which have been
proposed to describe neutral evolution and the resulting topologies. Phylogenetic trees
describe the evolutionary relationship between individuals with different traits from one
another, or in the case of our model, different mutational combinations (genotypes). In our
model, each simulation begins with a cell with mutation flag 1, or a genotype with the first
allele mutated (1000...), termed the ‘root’, and evolution progresses stochastically, by
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14 SCOTT ET AL.
adding individual mutations at subsequent alleles and increasing the mutation flag, as
described in Fig 1B. At each mutation event, an evolutionary branch point is created,
which is termed a node in phylogenetic tree terminology. If this node gives rise to no other
children during the simulation, it is termed a terminal node, or leaf. There are two
common, classically referenced models, which bear mention here as well, since many tree
topology-measures are normalized against them. The first, described by Yule (1925) and
sometimes termed the ‘equal rate Markov’ model, begins with a single root and proceeds
by replacing, uniformly at random, a given leaf with a node with two children of its own.
The process continues until the desired number of leaves exist. The other main model,
termed the ‘Proportional to Distinguishable Arrangements’ or uniform model, was
described by Rosen (1978). This model, which is truly a model of tree growth rather than
an explicitly evolutionary process, begins as does the Yule model (and indeed ours) with a
single node labelled 1. At each update step, a new leaf is added to the tree at any point,
either internal node or leaf. These models will serve as normalisation factors in several of
the measures we present below, which are summarised graphically in Fig 4.
Sackin index The Sackin index was the first statistic used to understand the
balance of a phylogenetic tree (Sackin 1972, Shao & Sokal 1990). To compute this statistic,
one sums the number of ancestors (Ni) for each of the n terminal nodes of the tree:
Ins =
n∑
i=1
Ni. (0.1)
This index increases with tree size: under the Yule growth model, its expectation E[Ins ]
grows as 2n log n (Yule 1925). One can therefore only perform a meaningful comparison of
Sackin indices of trees generated from tumours if they are the same size.
Normalized Sackin index To address this dependence on tree size, several
normalisations to the Sackin index have been proposed, two of which we explore here. In
particular, one can normalise the Sackin index of a phylogenetic tree to the expectation
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 15
value of a similarly sized tree, under the Yule growth model:
IY ule =
1
n
(
Ins − 2n
n+1∑
j=2
1
j
)
. (0.2)
One can alternatively normalise using the Proportional to Distinguishable Arrangements
(PDA) model (Aldous 1996, 2001, Rosen 1978) which is simply the Sackin index scaled by
n3/2.
The B1 statistic The B1 statistic, originally described by Shao & Sokal (1990),
considers the balance of a tree. To calculate the measure, one uses all i internal nodes of
the tree with the exception of the root (the founding cell). For each non-root internal node
j, the maximum number of nodes traversed along the longest possible path to a terminal
node, Mj, is counted. The B1 statistic is then defined as
B1 =
∑
i
1
Mj
∀i 6= root. (0.3)
N¯ The N¯ statistic reports the average number of nodes above a terminal node. To
compute this, we sum the path from each terminal node to the root, and divide by the
number of terminal nodes. An alternative definition is the Sackin index ‘normalised’ by the
number of terminal nodes. We define this as
N¯ =
1
n
n∑
i=1
Ni, (0.4)
where n is the number of tips and Ni is the number of internal nodes between tip i and the
root of the tree. For a more complete review and comparison of the measures presented
here, and others, see Blum & Franc¸ois (2005) and Shao & Sokal (1990).
Examples of how these measures change on several example trees with equal
numbers of leaves (but different numbers of internal nodes) are presented in Fig 4. (Note
that in contrast with these polytomous trees, our tumour growth model does not exhibit
polytomies, since all cell divisions are dichotomous and each node in the phylogenetic tree
is defined by a unique mutation in an infinite sites model.) In these examples, we compute
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16 SCOTT ET AL.
each of the presented measures for comparison. From left to right, the trees contain 4, 3
and 2 internal nodes, respectively, but the same number (6) of leaves. We note that the
measures do not all follow the same pattern. For an exhaustive description of all possible
trees with 6 leaves, and the correlation of a larger family of associated measures, see Shao
& Sokal (1990).
Results
Measuring trees from simulation
As our primary goal is to identify whether tree-based measures allow discrimination
of simulated tumours with different TIC symmetric division probabilities, we focus on
changes in tree measures as we vary comparable simulations changing only this parameter.
To compare the model tree measures, we first perform 50 stochastic simulations of both
our non-spatial and spatial CA using a range of TIC symmetric division probabilities
(0.2, 0.4, 0.6, 0.8 and 1.0), holding mutation rate and TAC lifetime constant (λ = 0.01 and
β = 4). For each simulation, we construct the resulting phylogenetic tree at tumour size
250, 000 cells, as described in the Materials and Methods section. We then measure the
Fig. 4.
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 17
value of each summary index defined earlier for all 50 simulations at the final time point
and plot the distribution in a box-whisker plot, which is shown in Fig 5 with each data
point overlaid in a swarm. Differences between distributions were determined using the
Wilcoxon rank sum test. While these statistics were performed post hoc, we should note
that standard statistics can be misleading for simulation based studies with arbitrarily
large sample sizes (White et al. 2014) (see Supplementary Fig 9 for effect size).
Variation of tree-based measures with symmetric division probability
The results of the model are presented in Fig 5. We find that all of the indices have
monotone relationships with symmetric division probabilities except for N¯ in the spatial
model, and B1 in the non-spatial model. Of note also, is that only in the Sackin index do
we see qualitative agreement for the spatial and non-spatial models (monotone up/down)
for both in the standard (normalized) Sackin model. This difference in utility of the
different models for spatial and non-spatial is not unexpected, as Shao & Sokal (1990) have
previously shown that even for similar questions, different models of tree topology will
have different uses. As our primary purpose is to understand the spatial cancer model, we
will leave a deeper investigation into the dynamics of the non-spatial model for future
work, and concentrate our analysis from here forward on the spatial model.
In terms of discernibility for the spatial model, of the normalised indices the B1
statistic has the least overlap in error between symmetric division probabilities (i.e.
comparing the cases α < 1 with the case α = 1). All measure distributions are significantly
different by the Wilcoxon rank sum test (p < 0.05) except 0.4 and 0.6 in the Sackin index
normalised by the Yule model (p = 0.08). While we recognize the dangers in reporting
p-values in simulation based studies (White et al. 2014), we report them here for
comparison, and report effect size as well, with full statistics for both the spatial and
non-spatial model reported in Fig 9. The strongest effect for the spatial model is seen in
the Sackin index (R2 = 0.871), followed by the Yule normalised Sackin index (R2 = 0.743).
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18 SCOTT ET AL.
Fig. 5.
Dynamics of tree-based measures during tumour growth
As discussed in Materials and Methods, the measures considered here are strongly
dependent on the total number of nodes in the tree. With all other parameters held
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 19
constant, simply allowing a tumour to grow larger would increase the number of total
mutations, and therefore the number of total nodes, subsequently altering the value of the
measure. To ensure that the differences we have noted are robust to changing tumour size,
we next consider how these measures evolve during the growth of a tumour.
Fig. 6.
To determine how these measures vary over the lifetime of a growing tumour, we
measure each index over the course of multiple simulations. To accomplish this, we use the
life history to reconstruct the phylogenetic tree at 20 equally spaced time points during the
course of 50 simulations for each value of the symmetric division probability. Note that
since the time taken for each simulated tumour to fill the spatial domain depends strongly
on the symmetric division probability (see Fig 2), to compare ‘like for like’ we break each
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20 SCOTT ET AL.
life history into equally spaced time intervals, which act as surrogates for tumour size.
Comparing across tumour size is of greater utility, clinically, since while the age of a given
tumour is rarely known, size can be readily estimated.
After reconstruction, we then create a ‘time’ trace for each statistic. We plot these
statistics over ‘time’ in Fig 6, where each family of 50 simulations (for a given symmetric
division probability) is represented by a single trace with the standard deviation
represented by the coloured error bars. We find that for each of the statistics, except N¯ ,
the relationships between the symmetric division probabilities are maintained over time,
suggesting that, if we know the tumour size, and true phylogeny, we can estimate the
relative symmetric division probability between two samples from these measures. This
statement must be somewhat qualified by the fact that mutation probability was also held
constant for these simulations. While estimating mutation probability is not trivial,
significant advances have been made in measuring the speed of the ‘evolutionary clock’ of
tumours: essentially a proxy for mutation probability (Curtius et al. 2016). Further, we
found that the rank order of each discriminatory measure holds throughout tumour
growth, indeed becoming more discriminatory as the tumours grow larger (with the
exception of N¯). As the tumours simulated in this study are unrealistically small given the
computational constraints, this information gives us hope that in tumours of realistic size,
these measures would be even more useful. This becomes particularly important as the
statistics that we have calculated come from the ‘true trees’, that is, trees comprised of all
mutation events. In reality, trees would be inferred from the imperfect information gleaned
from biopsies.
Dependence of tree-based measures on mutation probability
As the tree measures depend heavily on the number of mutations within a given
tumour, and therefore the number of branches within a given tree, we next ask how these
measures behave when we vary mutation probability (λ) and symmetric division
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INFERRING TUMOUR ORGANISATION FROM PHYLOGENETICS 21
probability simultaneously. To answer this, we perform 10 stochastic simulations for each
combination of the symmetric division probabilites considered previously and 5 different
values for λ varying over two orders of magnitude (0.001, 0.005, 0.01, 0.05, 0.1), which spans
most of the range (per cell per division) as noted by Alexandrov et al. (2013). We then use
the previously described method to reconstruct the resulting phylogenies and calculate the
measures previously discussed. In particular, we ask how the Sackin index, the B1 statistic
and the normalized Sackin index perform over this range of λ to better understand the
applicability of these measures in determining differences in symmetric division probability.
We plot the results of this parameter investigation in Fig 7. In each heat map, we
plot the mean of the 10 simulations for each parameter combination with symmetric
division probability varied along the horizontal axis and mutation probability along the
vertical axis. The indices which are not normalized by branch number, namely the Sackin
index and B1 statistic, increase monotonically with mutation probability and symmetric
division probability in all cases. The Sackin index normalised by the PDA model, however,
varies somewhat unexpectedly and has a global minimum at symmetric division
probability of 1.0 and mutation probability 0.01. This measure is monotonic in symmetric
division probability except at the highest mutation probability where it becomes somewhat
more difficult to determine the differences. As before, the B1 statistic appears to be the
most stable, and only breaks down slightly in its ability to distinguish between the families
of simulations at the lowest mutation probability (λ = 0.001) and the middle range of
symmetric division probability (symmetric division probabilities = 0.4− 0.8), as can be
seen in Fig 7. In these ranges of the parameter space our model may not provide useful
predictive power.
Discussion
While the use of phylogenetic trees is increasing in translational oncology
laboratories, there has yet to be a method found by which we can utilise the information
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Fig. 7.
clinically. To address this shortcoming, we worked to leverage the growing interest in
biomarker derivation from spatially distinct tumour biopsies (Dhawan, Graham & Fletcher
2016), and the recent success of Leventhal et al. (2012) and others in teasing apart complex
biological rules from phylogenetic information. We developed an individual based model of
tumour growth under a TIC driven proliferative heterogeneity which undergoes neutral
evolution. We then developed an algorithm to construct phylogenetic trees from simulated
tumours. The resultant trees were then analysed and compared using a suite of statistical
measures of tree (im)balance. Through this method, we have generated a large dataset that
includes the observed statistical measures of the ‘true’ phylogeny for tumours spanning the
full range possible of symmetric division probabilities, which we feel is appropriate as
symmetric division probabilities as low as 5% have been reported in glioblastoma (Lathia
et al. 2011) and as high as 90% have been reported in colorectal cancer (Baker et al. 2014).
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It is worth noting that, as our phylogenies are exact, some of the conclusions one may
draw in the future from empirically inferred trees would have to be tempered by the
inherent uncertainty in the inference process. Further, we are by no means the first group
to seek to utilize simulation to study tree topology, with notable recent examples being
INDELible, a flexible platform to simulation insertions and deletions (Fletcher & Yang
2009), as well earlier models of simulating neutral Wright-Fisher models (Hudson 2002).
In particular, we compared the classical measures of tree topology – the Sackin
index and the B1 statistic – as well as normalized versions of each across several
parameters of our spatial and non-spatial models as well as through the process of tumour
growth. Not surprisingly, we found that the Sackin index was able to discriminate between
the families of simulations as it is directly correlated with branch number (in this case
correlating with total number of mutations in the TICs, which also is increased with
increasing symmetric division probability). Encouragingly, we also found that the
normalised version of this metric was able to discriminate between the different symmetric
division probabilities, suggesting a more meaningful (and measurable) topological
difference between the underlying phylogenetic trees resulting from these parameter
changes (representing diverse biological traits).
While we have shown that these measures differ significantly from one another, we
have not yet provided a method by which we can use the metric of a given tree to directly
predict the symmetric division probability of an unknown tumour. However, the present
work at least allows us to understand the rank order of symmetric division rate for two
tumours given their measured indices. This could be particularly useful in certain clinical
settings. For example, this could allow us to determine how a given therapy affects
symmetric division probability by using our calculated measures over serial biopsies, and
subsequent phylogenetic reconstruction. This could prove particularly useful in the
treatment of leukemias, where the target cell is known to be the TIC, eradication of which
is a requirement for cure (Roeder et al. 2006). In this case, after phylogenetic
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reconstruction using any of several methods available for single sample whole genome
sequencing (Carter et al. 2012, Roth et al. 2014, Deshwar et al. 2015), the tree topologies
could be compared before and after therapy, giving a measure of relative change. Our
metric (derived in this case from our non-spatial model results) could therefore prove a
useful adjunct to existing methods of predicting TIC fraction (Werner et al. 2016) to
determine therapeutic efficacy, and guide therapy breaks or switching.
Even with state-of-the-art multi-region sequencing approaches, most reconstructed
cancer phylogenies are relatively small (Gerlinger et al. 2014, Zhao et al. 2016) with very
few leaves, preventing the application of our statistical method in its current form. With
continued advances in single-cell sequencing, and more examples of higher spatial sampling
from larger tumors, like in the most recent TRACERx Renal study (Turajlic et al. 2018),
the situation may change, but it is worth reiterating that this theory has not yet been
shown to be quantitatively accurate in real tumor samples. Even in the case that it does
not become effective in the near future, however, we assert that beginning to use metrics of
tree topology to compare tumors before and after therapy, or across grade or survival,
could prove useful to enhance our understanding of tumour evolution and treatment
response in the near term.
Aiming towards a translatable method by which to infer the symmetric division
probability in solid tumours, we have identified several phylogenetic tree based measures
that correlate with TIC symmetric division probability. We have found several measures
which are able to discern differences in simulated tumours between symmetric division
probabilities. These results are robust to changes in tumour size, specifically maintaining
their rank throughout tumour growth. The rate of mutation does affect these results to
some degree, but rank is maintained permitting comparison through time, or between
tumours of similar size.
While there is some overlap amongst the measures when more than one parameter
is varied, with information on mutation probability and tumour size, relative symmetric
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division probability can be estimated. We have restricted our focus to measures of
(im)balance, a basic property of phylogenetic trees based only on their branching topology.
With more information, such as evolutionary branch lengths (Kirkpatrick & Slatkin 1993,
Mooers & Heard 1997) which are linked to the ‘speed’ of a tumour’s molecular
clock (Curtius et al. 2016), some of these limitations could be obviated. Further, we have
only considered neutral evolution. While most tumour evolution is likely neutral (Williams
et al. 2016), there is certainly evidence for non-neutrality in the form of driver and
passenger mutations (McFarland et al. 2013, 2017), which would drastically affect the
resulting phylogenetic trees (Grenfell et al. 2004) – especially with intervening treatment
regimens. How non-neutral evolution and treatment affect our measures remain avenues for
future work.
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Supplementary Material
Pruning trees does not affect rank of statistics
To visualize the trees more easily in Fig 3, we prune the leaves from each full tree.
While this changes the absolute value of each of the tree-based measures, it does not affect
their relative ranking. This suggests that each measure is capturing something fundamental
about the biology as it appears invariant with tree size. This is corroborated by the results
shown in Fig 6, indicating that the rank of each measure is stable over tumour growth.
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Effect size of symmetric division probability
To better understand the impact of the symmetric division probability on changes in
the resulting tree topology, rather than just use differences between families of simulations,
we compute the regression slope, R2 and p-value of the regression line for each case. For
the B1 statistic we find a regression slope of 142.64, R2 = 0.72, p = 1.74× 10−71, and in the
non-spatial model a regression slope of −13.2, R2 = 0.056, p = 1.7× 10−5. For the Sackin
index we find a regression slope of 5178.61, R2 = 0.871, p ≈ 0, and in the non-spatial
model a regression slope of 3690.92, R2 = 0.8673, p ≈ 0. For the Yule normalised Sackin
index we find a regression slope of −2.380, R2 = 0.743, p = 3.25× 10−75, and in the
non-spatial model a regression slope of −3.118, R2 = 0.948, p ≈ 0. For the N¯ statistic we
find a regression slope of −0.111, R2 = 0.0075, p = 0.172, and in the non-spatial model a
regression slope of −0.457, R2 = 0.303, p = 3.33× 10−21. These values are plotted in Fig 9.
Fig. 9.
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Algorithm for generating individual cell ‘genomes’ from mutational flag and life history
Our algorithm to reconstruct individual cell ‘genomes’ from the mutational flag and
life history allows for significant increase in speed of our tumour growth model and
reduced memory requirements by several orders of magnitude. While there are many tree
reconstruction algorithms available to infer phylogenies from real data, most notably
PHYLIP (Felsenstein 1981), as our data are ‘perfect data’ from our simulation, and
therefore in a bespoke data structure, there is no inference required, and the task is a
simple recursive tree building algorithm, which proceeds per the pseudocode below. Code
is available at: https://github.com/cancerconnector/clonal_evolution.git
Algorithm 1: Pseudo-code describing algorithm to reconstruct genomes from
unique mutation flags and family history.
Data: Dictionary of unique Parent:Child pairs and spatial array of unique
mutation flags at time point of interest.
Result: Array of bitstrings representing ‘genomes’ of cells in array.
for All cells in array do
if mutation ID = 0 then
break
end
set bitstring to ’1’ + maxval(mutation ID) ’0’;
final-parent = 2;
if mutation ID = 1 then
finalize bitstring
end
while final-parent > 1 do
final-parent = lookup parent(cell of interest) in dictionary;
flip bitstring at position(cell of interest) to ’1’;
end
finalize bitstring;
end
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Fig 1. Spatial stochastic model schematic with neutral mutation schema.
(A) The proliferative hierarchy. Each TIC can divide symmetrically with probability α to
make two identical TIC progeny, or asymmetrically with probability (1− α) to make one
TIC and one TAC. TACs divide symmetrically until they reach a specific divisional age
(β = 4 for this work), after which they die upon division attempt. (B) At each division
event (branching) after the first (carcinogenesis, labelled with a 1), a random number of
mutations drawn from a Poisson distribution with expectation λ is conferred on each
daughter (subsequent starred events). Each mutation event is given a unique flag, which is
inherited by its offspring unless they too mutate. Each unique mutation can then be
considered as a novel mutant allele (red) appearing in the population. (C) Flowchart
outlining cellular automaton rules governing TIC and TAC growth, including spatial
inhibition of growth and TAC age.
Fig 2. Temporal evolution of the spatial model reveals observable
morphologic differences between TIC-driven and non-TIC-driven tumours, as
observed by others. We plot representative results of simulations of two tumours, each
simulated on a square lattice of size 400× 400. Top: a tumour simulated with α = 0.2 and
β = 4. We notice, as have Enderling et al. (2009) and Sottoriva et al. (2010), a ‘patchy’
clonal architecture, and non-uniform edge. Bottom: a tumour simulated with α = 1.0, i.e.
no proliferative hierarchy. We note smooth edges, radial patterns of clonal architecture and
relatively faster population growth, reaching ≈ 70, 000 cells in less than 200 time steps. To
reach a similar size, the tumour with symmetric division probability of 0.2 took 35, 000
time steps. Colour bars denote number of mutations present in a given clone, note that the
top scale is about 1/3 of bottom scale.
Fig 3. Three example simulations with increasing symmetric division
probability, α (0.2, 0.6 and 1.0 from top to bottom) and their associated
phylogenetic trees. Each example plot is the result of a single stochastic simulation of
our spatial CA model. Each simulation is initiated with a single TIC and complete when
http://mc.manuscriptcentral.com/systbiol
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the domain is full, in this case 250, 000 cells. Parameter values are β = 4 and λ = 0.01.
Visualized trees (right) have been pruned of all leaves for ease of visualisation, which does
not qualitatively affect measure rank (see Fig 8).
Fig 4. Example phylogenetic trees and their measures. From left to right
the trees contain 4, 3 and 2 internal nodes (dots) respectively, but the same number (6) of
terminal nodes.
Fig 5. A summary of four tree indices measured over a range of
symmetric division probability. We plot the distribution of each of four measures of
tree balance for the final resultant trees from 50 simulations against symmetric division
probability. All simulations were run with β = 4 and λ = 0.01 until a tumour size of
250, 000 cells was reached. In each plot we display a box-whisker plot as well as the
individual results as points. NS = non-significant by the Wilcoxon rank sum test.
Fig 6. Comparing phylogenetic tree measures across symmetric division
probability through tumour growth. We plot the average and standard deviation
(error bars) of four phylogenetic tree measures for each of the 50 simulations for a range of
symmetric division probabilities over the course of tumour growth. Rank is maintained
across symmetric division probabilities for each of the 3 tree measures with which we could
discriminate between symmetric division probabilities. As before, N¯ is not predictive and
changes rank throughout tumour growth. All tumours are grown to eventual confluence at
250, 000 cells. In all simulations β = 4 and λ = 0.01.
Fig 7. Comparing phylogenetic tree measures across symmetric division
probability and mutation probability. We plot the average of each of four
phylogenetic tree measures at the end of each of 10 simulations for a range of symmetric
division probabilities and mutation probabilities. We vary mutational probability over two
orders of magnitude (0.1− 0.001), and simulate all tested symmetric division probabilities.
Rank is maintained across symmetric division probabilities for each of the three of the four
measures with which we could discriminate between symmetric division probabilities with
http://mc.manuscriptcentral.com/systbiol
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changing mutation probability, allowing for differentiation between parameters. As before,
the N¯ statistic is not predictive. As expected, for the non-normalized indices, Sackin and
B1, the measures change monotonically with both symmetric division and mutation
probability. For the PDA normalized Sackin index, however, there is a global minimum for
λ = 0.01 and α = 1.
Supplementary Fig 8. Raw and pruned trees give rise to qualitatively
similar summary measures with rank preserved. For each tree-based measure
considered in the main text, we plot the measure based on the full (upper) and pruned
(lower) tree. For each pair, we plot the results from 10 simulations for each of the tested
symmetric division probabilities. From left to right, we plot the B1 statistic, N¯ , the Sackin
index, the PDA normalised Sackin index and finally the Yule normalised Sackin index.
Supplementary Fig 9. Effect size of symmetric division for four
tree-based measures. We plot the effect size for the data shown in Fig 5.
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